Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07469579 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ALPs Single ChambEr New Device Study

Study acronym: ASCEND
StatusNot Yet Recruiting
PhaseNot applicable
SponsorCairdac SA
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description shortened, about 1 wordv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Prospective, non-randomized, multi-center, international study designed to evaluate the initial safety and performance of the ALPS leadless pacemaker when used in patients with bradycardia.
Trial Details
NCT Number NCT07469579
Lead Sponsor Cairdac SA
Conditions
(from sponsor)		 Brady-tachy Syndrome, Brady Arrythmia, Bradycardia, AV Block, Atrial Fibrillation (Paroxysmal)
Related terms Atrial Fibrillation, Atrioventricular Block, Bradycardia
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov